Overview

Full Product Details

Author:   J. Venitz ,  W. Sittner
Publisher:   Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
Imprint:   Springer-Verlag Berlin and Heidelberg GmbH & Co. K
Edition:   2007 ed.
Volume:   59
Dimensions:   Width: 14.90cm , Height: 1.60cm , Length: 21.10cm
Weight:   0.477kg
ISBN:  

9783540278672

ISBN 10:   3540278672
Pages:   216
Publication Date:   19 October 2006
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Out of stock  
The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available.

Table of Contents

Extrapolation of Preclinical Data into Clinical Reality — Translational Science.- Smarter Candidate Selection — Utilizing Microdosing in Exploratory Clinical Studies.- The Applications of Biomarkers in Early Clinical Drug Development to Improve Decision-Making Processes.- Using Exposure — Response and Biomarkers to Streamline Early Drug Development.- Experiences with Dose Finding in Patients in Early Drug Development: The Use of Biomarkers in Early Decision Making.- Genotype and Phenotype Relationship in Drug Metabolism.- Clinical Trials in Elderly Patients.- Dose Finding in Pediatric Patients.- Integration of Pediatric Aspects into the General Drug Development Process.- Current Stumbling Blocks in Oncology Drug Development.- Exploratory IND: A New Regulatory Strategy for Early Clinical Drug Development in the United States.- Ethnic Aspects of Cancer Trials in Asia.- Evaluation of the Effect on Cardiac Repolarization (QTc Interval) of Oncologic Drugs.- The Role of PET Scanning in Determining Pharmacoselective Doses in Oncology Drug Development.- Biometrical Aspects of Drug Development.- Preventing Postmarketing Changes in Recommended Doses and Marketing Withdrawals.

Reviews

Author Information

Tab Content 6

Author Website:  

Countries Available

All regions